Literature DB >> 15299278

Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.

D Angoulvant1, A Clerc, S Benchalal, C Galambrun, A Farre, Y Bertrand, A Eljaafari.   

Abstract

Mesenchymal stem cells (MSC) fail to induce allogeneic responses in mixed lymphocyte reaction assays. Because MSC express HLA class I molecules, here we investigated whether they could be recognized as allogeneic targets by cytolytic T lymphocytes (CTL). With this aim, CTL precursor (CTLp) frequencies were measured following stimulation of T cells with either allogeneic mononuclear cells (MNC) or MSC originated from the same human bone marrow donor. Lysis of MSC was measured at day 10 of culture in standard chromium release assays. In addition, allogeneic PHA blast T cells or B-EBV lymphoblastoid cell lines (LCLs) generated from the same donor were used as positive controls of lysis. Our results showed that when allogeneic MNC were used to stimulate T cells, a high CTLp frequency was detected towards MSC targets. However, when MSC were used as stimulators, CTLp frequencies were markedly altered whatever the targets used, i.e.: MSC, PHA blast T cells or EBV-B LCLs. Moreover, when graded concentrations of MSC were added together with MNC upon stimulation of alloreactive T cells, we observed a dose-dependent decrease in CTLp frequencies towards MSC targets. This inhibition of MSC lysis was partially overcome by adding exogenous rh-IL-2 from the beginning of cultures. In addition, this suppressive effect was totally reproduced when, instead of MSC, supernatant harvested from MSC cultures was added to allogeneic MNC, upon stimulation of alloreactive T cells. In conclusion, our results demonstrate that MSC which can be recognized as targets by pre-activated alloreactive CTLs, may be able to suppress differentiation of CTL precursors into CTL effectors through secretion of suppressive factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299278

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  25 in total

1.  Evaluation of early healing events around mesenchymal stem cell-seeded collagen-glycosaminoglycan scaffold. An experimental study in Wistar rats.

Authors:  Mohamed Alhag; Eric Farrell; Mary Toner; Noel Claffey; T Clive Lee; Fergal O'Brien
Journal:  Oral Maxillofac Surg       Date:  2010-07-20

2.  HSCT recipients have specific tolerance to MSC but not to the MSC donor.

Authors:  Mikael Sundin; A John Barrett; Olle Ringdén; Mehmet Uzunel; Helena Lönnies; Asa-Lena Dackland; Birger Christensson; Katarina Le Blanc
Journal:  J Immunother       Date:  2009-09       Impact factor: 4.456

3.  Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate.

Authors:  Antoinette Flemming; Katharina Schallmoser; Dirk Strunk; Meaghan Stolk; Hans-Dieter Volk; Martina Seifert
Journal:  J Clin Immunol       Date:  2011-09-02       Impact factor: 8.317

4.  Immunological properties of embryonic and adult stem cells.

Authors:  Francesco Bifari; Luciano Pacelli; Mauro Krampera
Journal:  World J Stem Cells       Date:  2010-06-26       Impact factor: 5.326

Review 5.  Rationale for the potential use of mesenchymal stromal cells in liver transplantation.

Authors:  Morgan Vandermeulen; Céline Grégoire; Alexandra Briquet; Chantal Lechanteur; Yves Beguin; Olivier Detry
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 6.  Secretion of immunoregulatory cytokines by mesenchymal stem cells.

Authors:  Dobroslav Kyurkchiev; Ivan Bochev; Ekaterina Ivanova-Todorova; Milena Mourdjeva; Tsvetelina Oreshkova; Kalina Belemezova; Stanimir Kyurkchiev
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

7.  Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment.

Authors:  Vladimir Holan; Barbora Hermankova; Pavla Bohacova; Jan Kossl; Milada Chudickova; Michaela Hajkova; Magdalena Krulova; Alena Zajicova; Eliska Javorkova
Journal:  Stem Cell Rev Rep       Date:  2016-12       Impact factor: 5.739

Review 8.  Concise review: adult multipotent stromal cells and cancer: risk or benefit?

Authors:  Gwendal Lazennec; Christian Jorgensen
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

9.  Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.

Authors:  Jeroen Plessers; Emily Dekimpe; Matthias Van Woensel; Valerie D Roobrouck; Dominique M Bullens; Jef Pinxteren; Catherine M Verfaillie; Stefaan W Van Gool
Journal:  Stem Cells Transl Med       Date:  2016-07-27       Impact factor: 6.940

Review 10.  Mesenchymal stromal cells: current understanding and clinical status.

Authors:  Husein K Salem; Chris Thiemermann
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.